The promises of such therapeutics in treatments against tumor recurrence and metastasis have also been evaluated, illuminating the significances of pre-activation of T cell immunity IFN-γ-potentiated in vivo ferroptotic therapy. The gene discussed is IFNG; the disease is neoplasm.